- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Datroway joins Trodelvy for frontline TNBC in the EU | ||
| Fr | Apnimed IPO raises $192m, as three other biotechs set terms | ||
| Fr | Adcomm backs Replimune melanoma drug, despite data concern | ||
| Do | Pfizer cues up vitiligo filing for Litfulo after phase 3 win | ||
| Do | UK patient first in world to get novel lung cancer vaccine | ||
| Do | Sanofi drops two more programmes in R&D clear-out | ||
| Do | Cytokinetics' cardiomyopathy drug cleared for NHS use | ||
| Do | J&J takes $2.58bn option to buy in vivo CAR-T firm Sail | ||
| Do | Lawmakers seek answers from RFK on Gardasil shot settlement | ||
| Do | FDA advisors vote no to Capricor's DMD therapy | ||
| Mi | Simple blood test could aid in global TB fight | ||
| Mi | Leqembi sales grow again after subcutaneous approvals | ||
| Mi | EU first to clear AbbVie's Rinvoq for alopecia areata | ||
| Mi | Altimmune alcohol use disorder drug hits the mark in phase 2 | ||
| Mi | US judge says Novo Nordisk must face lawsuit over CagriSema | ||
| Di | GSK to quit Stevenage for new R&D site in Cambridge | ||
| Di | HIV resurgence looming as international aid declines | ||
| Di | Severino takes the helm at Sarepta after turbulent spell | ||
| Di | Scribe Therapeutics raises $155m in IPO, as Apnimed pitches for $150m | ||
| Di | Is J&J approaching the end of its talc litigation hangover? | ||
| 27.07. | J&J's oral IL-23 drug backed for psoriasis in EU | ||
| 27.07. | Chris McDonald replaces Vallance as UK science minister | ||
| 27.07. | Outlook finally claims FDA approval for AMD drug | ||
| 27.07. | Argenx pens $2.2bn deal to buy autoimmune biotech Forte | ||
| 27.07. | Ultomiris fail mars AZ's strong Q2 results |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.